⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SKYE News
Skye Bioscience, Inc. Common Stock
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
globenewswire.com
SKYE
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
globenewswire.com
SKYE
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm
globenewswire.com
SKYE
Lifshitz Law PLLC Announces Investigations of StubHub Holdings, Inc. (NYSE:STUB), Skye Bioscience, Inc. (NASDAQ:SKYE), Primo Brands Corporation (NYSE:PRMB), and Freeport-McMoRan Inc. (NYSE:FCX)
accessnewswire.com
STUB
SKYE
PRMB
FCX
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
globenewswire.com
SKYE
Form 8-K/A
sec.gov
SKYE
Form 8-K
sec.gov
SKYE
LGND
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
globenewswire.com
SKYE
Skeyeon Secures Key Patent for Very-Low Earth Orbit Satellite Constellations with Onboard Imaging and Direct-to-Ground Data Delivery Enabling Near-Real-Time Earth Observation
businesswire.com
SKYE
Form 8-K
sec.gov
SKYE